A Man with Primary Hyperchylomicronemia with Triglyceride Levels Exceeding 11,000 mg/dL Was Well Controlled by Pemafibrate Combined with Dietary Therapy Article Swipe
Hiroyuki Ueda
,
Ryohei Mineo
,
Takuya Sugiyama
,
Masahiro Koseki
,
Yoshito Itoh
,
Ryuya Iwamoto
,
Sachiko Tamba
,
Koji Yamamoto
,
Yuya Yamada
,
Hisatoyo Hiraoka
,
Yūji Matsuzawa
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2169/internalmedicine.3946-24
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2169/internalmedicine.3946-24
A 50-year-old man with a triglyceride (TG) level of 11,397 mg/dL was admitted to our hospital. He consumed a high-fat and high-carbohydrate diet as well as more than 100 g of alcohol per day. He had type 2 diabetes and obesity and had previously suffered from severe acute pancreatitis twice. A genetic analysis revealed compound heterozygous mutations in APOA5 (c.56C>G and c.553G>T). In addition to low-fat meals and alcohol cessation, administration of pemafibrate lowered his triglyceride levels to <150 mg/dL.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2169/internalmedicine.3946-24
- https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdf
- OA Status
- diamond
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4400939006
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4400939006Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2169/internalmedicine.3946-24Digital Object Identifier
- Title
-
A Man with Primary Hyperchylomicronemia with Triglyceride Levels Exceeding 11,000 mg/dL Was Well Controlled by Pemafibrate Combined with Dietary TherapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-07-24Full publication date if available
- Authors
-
Hiroyuki Ueda, Ryohei Mineo, Takuya Sugiyama, Masahiro Koseki, Yoshito Itoh, Ryuya Iwamoto, Sachiko Tamba, Koji Yamamoto, Yuya Yamada, Hisatoyo Hiraoka, Yūji MatsuzawaList of authors in order
- Landing page
-
https://doi.org/10.2169/internalmedicine.3946-24Publisher landing page
- PDF URL
-
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdfDirect OA link when available
- Concepts
-
Medicine, Triglyceride, Obesity, Type 2 diabetes, Acute pancreatitis, Medium-chain triglyceride, Internal medicine, Diabetes mellitus, Alcohol, Endocrinology, Gastroenterology, Animal science, Cholesterol, Biochemistry, Biology, ChemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4400939006 |
|---|---|
| doi | https://doi.org/10.2169/internalmedicine.3946-24 |
| ids.doi | https://doi.org/10.2169/internalmedicine.3946-24 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39048362 |
| ids.openalex | https://openalex.org/W4400939006 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D008875 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Middle Aged |
| mesh[3].qualifier_ui | Q000097 |
| mesh[3].descriptor_ui | D014280 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | blood |
| mesh[3].descriptor_name | Triglycerides |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D002087 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Butyrates |
| mesh[5].qualifier_ui | Q000627 |
| mesh[5].descriptor_ui | D001583 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | therapeutic use |
| mesh[5].descriptor_name | Benzoxazoles |
| mesh[6].qualifier_ui | Q000178 |
| mesh[6].descriptor_ui | D015228 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | diet therapy |
| mesh[6].descriptor_name | Hypertriglyceridemia |
| mesh[7].qualifier_ui | Q000178 |
| mesh[7].descriptor_ui | D008072 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | diet therapy |
| mesh[7].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[8].qualifier_ui | Q000097 |
| mesh[8].descriptor_ui | D008072 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | blood |
| mesh[8].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[9].qualifier_ui | Q000235 |
| mesh[9].descriptor_ui | D008072 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | genetics |
| mesh[9].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[10].qualifier_ui | Q000188 |
| mesh[10].descriptor_ui | D008072 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | drug therapy |
| mesh[10].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[11].qualifier_ui | Q000150 |
| mesh[11].descriptor_ui | D003924 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | complications |
| mesh[11].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008297 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Male |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008875 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Middle Aged |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D001583 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Benzoxazoles |
| mesh[16].qualifier_ui | Q000097 |
| mesh[16].descriptor_ui | D014280 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | blood |
| mesh[16].descriptor_name | Triglycerides |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D002087 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Butyrates |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D000960 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Hypolipidemic Agents |
| mesh[19].qualifier_ui | Q000008 |
| mesh[19].descriptor_ui | D000960 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | administration & dosage |
| mesh[19].descriptor_name | Hypolipidemic Agents |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D018752 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Diet, Fat-Restricted |
| mesh[21].qualifier_ui | Q000235 |
| mesh[21].descriptor_ui | D008072 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | genetics |
| mesh[21].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[22].qualifier_ui | Q000175 |
| mesh[22].descriptor_ui | D008072 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | diagnosis |
| mesh[22].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[23].qualifier_ui | Q000097 |
| mesh[23].descriptor_ui | D008072 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | blood |
| mesh[23].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D008072 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D016896 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Treatment Outcome |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D006801 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Humans |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008297 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Male |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D008875 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Middle Aged |
| mesh[29].qualifier_ui | Q000627 |
| mesh[29].descriptor_ui | D001583 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | therapeutic use |
| mesh[29].descriptor_name | Benzoxazoles |
| mesh[30].qualifier_ui | Q000097 |
| mesh[30].descriptor_ui | D014280 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | blood |
| mesh[30].descriptor_name | Triglycerides |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D002087 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Butyrates |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D000960 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Hypolipidemic Agents |
| mesh[33].qualifier_ui | Q000008 |
| mesh[33].descriptor_ui | D000960 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | administration & dosage |
| mesh[33].descriptor_name | Hypolipidemic Agents |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D018752 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Diet, Fat-Restricted |
| mesh[35].qualifier_ui | Q000235 |
| mesh[35].descriptor_ui | D008072 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | genetics |
| mesh[35].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[36].qualifier_ui | Q000175 |
| mesh[36].descriptor_ui | D008072 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | diagnosis |
| mesh[36].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[37].qualifier_ui | Q000097 |
| mesh[37].descriptor_ui | D008072 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | blood |
| mesh[37].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D008072 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | Hyperlipoproteinemia Type I |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D016896 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Treatment Outcome |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008297 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Male |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D008875 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Middle Aged |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D001583 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Benzoxazoles |
| mesh[44].qualifier_ui | Q000097 |
| mesh[44].descriptor_ui | D014280 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | blood |
| mesh[44].descriptor_name | Triglycerides |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D002087 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Butyrates |
| mesh[46].qualifier_ui | Q000627 |
| mesh[46].descriptor_ui | D000960 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | therapeutic use |
| mesh[46].descriptor_name | Hypolipidemic Agents |
| mesh[47].qualifier_ui | Q000008 |
| mesh[47].descriptor_ui | D000960 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | administration & dosage |
| mesh[47].descriptor_name | Hypolipidemic Agents |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D018752 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Diet, Fat-Restricted |
| mesh[49].qualifier_ui | Q000235 |
| mesh[49].descriptor_ui | D008072 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | genetics |
| mesh[49].descriptor_name | Hyperlipoproteinemia Type I |
| type | article |
| title | A Man with Primary Hyperchylomicronemia with Triglyceride Levels Exceeding 11,000 mg/dL Was Well Controlled by Pemafibrate Combined with Dietary Therapy |
| biblio.issue | 5 |
| biblio.volume | 64 |
| biblio.last_page | 747 |
| biblio.first_page | 741 |
| topics[0].id | https://openalex.org/T13430 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Lipid metabolism and disorders |
| topics[1].id | https://openalex.org/T11072 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9983000159263611 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Peroxisome Proliferator-Activated Receptors |
| topics[2].id | https://openalex.org/T11339 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9983000159263611 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Metabolism, Diabetes, and Cancer |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8838832378387451 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2778913445 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8346381783485413 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q186319 |
| concepts[1].display_name | Triglyceride |
| concepts[2].id | https://openalex.org/C511355011 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5900238752365112 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[2].display_name | Obesity |
| concepts[3].id | https://openalex.org/C2777180221 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5696600079536438 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[3].display_name | Type 2 diabetes |
| concepts[4].id | https://openalex.org/C2776670229 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5556565523147583 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q854573 |
| concepts[4].display_name | Acute pancreatitis |
| concepts[5].id | https://openalex.org/C2779014545 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5505483746528625 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q418295 |
| concepts[5].display_name | Medium-chain triglyceride |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5291695594787598 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C555293320 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4930371940135956 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[7].display_name | Diabetes mellitus |
| concepts[8].id | https://openalex.org/C2781066024 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4307669401168823 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q156 |
| concepts[8].display_name | Alcohol |
| concepts[9].id | https://openalex.org/C134018914 |
| concepts[9].level | 1 |
| concepts[9].score | 0.422040730714798 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[9].display_name | Endocrinology |
| concepts[10].id | https://openalex.org/C90924648 |
| concepts[10].level | 1 |
| concepts[10].score | 0.34987562894821167 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[10].display_name | Gastroenterology |
| concepts[11].id | https://openalex.org/C140793950 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3207566738128662 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q168091 |
| concepts[11].display_name | Animal science |
| concepts[12].id | https://openalex.org/C2778163477 |
| concepts[12].level | 2 |
| concepts[12].score | 0.19354259967803955 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q43656 |
| concepts[12].display_name | Cholesterol |
| concepts[13].id | https://openalex.org/C55493867 |
| concepts[13].level | 1 |
| concepts[13].score | 0.17920276522636414 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[13].display_name | Biochemistry |
| concepts[14].id | https://openalex.org/C86803240 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[14].display_name | Biology |
| concepts[15].id | https://openalex.org/C185592680 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[15].display_name | Chemistry |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8838832378387451 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/triglyceride |
| keywords[1].score | 0.8346381783485413 |
| keywords[1].display_name | Triglyceride |
| keywords[2].id | https://openalex.org/keywords/obesity |
| keywords[2].score | 0.5900238752365112 |
| keywords[2].display_name | Obesity |
| keywords[3].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[3].score | 0.5696600079536438 |
| keywords[3].display_name | Type 2 diabetes |
| keywords[4].id | https://openalex.org/keywords/acute-pancreatitis |
| keywords[4].score | 0.5556565523147583 |
| keywords[4].display_name | Acute pancreatitis |
| keywords[5].id | https://openalex.org/keywords/medium-chain-triglyceride |
| keywords[5].score | 0.5505483746528625 |
| keywords[5].display_name | Medium-chain triglyceride |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5291695594787598 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[7].score | 0.4930371940135956 |
| keywords[7].display_name | Diabetes mellitus |
| keywords[8].id | https://openalex.org/keywords/alcohol |
| keywords[8].score | 0.4307669401168823 |
| keywords[8].display_name | Alcohol |
| keywords[9].id | https://openalex.org/keywords/endocrinology |
| keywords[9].score | 0.422040730714798 |
| keywords[9].display_name | Endocrinology |
| keywords[10].id | https://openalex.org/keywords/gastroenterology |
| keywords[10].score | 0.34987562894821167 |
| keywords[10].display_name | Gastroenterology |
| keywords[11].id | https://openalex.org/keywords/animal-science |
| keywords[11].score | 0.3207566738128662 |
| keywords[11].display_name | Animal science |
| keywords[12].id | https://openalex.org/keywords/cholesterol |
| keywords[12].score | 0.19354259967803955 |
| keywords[12].display_name | Cholesterol |
| keywords[13].id | https://openalex.org/keywords/biochemistry |
| keywords[13].score | 0.17920276522636414 |
| keywords[13].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.2169/internalmedicine.3946-24 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S154471048 |
| locations[0].source.issn | 0918-2918, 1349-7235 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0918-2918 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Internal Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310313351 |
| locations[0].source.host_organization_name | The Japanese Society of Internal Medicine |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310313351 |
| locations[0].source.host_organization_lineage_names | The Japanese Society of Internal Medicine |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Internal Medicine |
| locations[0].landing_page_url | https://doi.org/10.2169/internalmedicine.3946-24 |
| locations[1].id | pmid:39048362 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Internal medicine (Tokyo, Japan) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39048362 |
| locations[2].id | pmh:oai:europepmc.org:10760984 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11949665 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5077739319 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3938-2208 |
| authorships[0].author.display_name | Hiroyuki Ueda |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[0].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Sumitomo Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hiroyuki Ueda |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[1].author.id | https://openalex.org/A5085960129 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Ryohei Mineo |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[1].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Sumitomo Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ryohei Mineo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[2].author.id | https://openalex.org/A5074585691 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4202-5594 |
| authorships[2].author.display_name | Takuya Sugiyama |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[2].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Sumitomo Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Takuya Sugiyama |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[3].author.id | https://openalex.org/A5064350710 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1852-9319 |
| authorships[3].author.display_name | Masahiro Koseki |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I98285908 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I98285908 |
| authorships[3].institutions[0].ror | https://ror.org/035t8zc32 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I98285908 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | The University of Osaka |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Masahiro Koseki |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan |
| authorships[4].author.id | https://openalex.org/A5043046303 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2630-688X |
| authorships[4].author.display_name | Yoshito Itoh |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[4].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Sumitomo Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yoshito Itoh |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[5].author.id | https://openalex.org/A5002490822 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Ryuya Iwamoto |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[5].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Sumitomo Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ryuya Iwamoto |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[6].author.id | https://openalex.org/A5057601887 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Sachiko Tamba |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[6].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Sumitomo Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sachiko Tamba |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[7].author.id | https://openalex.org/A5025204867 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4624-1649 |
| authorships[7].author.display_name | Koji Yamamoto |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[7].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Sumitomo Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Koji Yamamoto |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[8].author.id | https://openalex.org/A5103071366 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Yuya Yamada |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[8].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Sumitomo Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Yuya Yamada |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[9].author.id | https://openalex.org/A5110784454 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Hisatoyo Hiraoka |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Cardiology, Sumitomo Hospital, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[9].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Sumitomo Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Hisatoyo Hiraoka |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Cardiology, Sumitomo Hospital, Japan |
| authorships[10].author.id | https://openalex.org/A5109934217 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Yūji Matsuzawa |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210117281 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I4210117281 |
| authorships[10].institutions[0].ror | https://ror.org/02m9ewz37 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210117281 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Sumitomo Hospital |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Yuji Matsuzawa |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Endocrinology and Metabolism, Sumitomo Hospital, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-07-25T00:00:00 |
| display_name | A Man with Primary Hyperchylomicronemia with Triglyceride Levels Exceeding 11,000 mg/dL Was Well Controlled by Pemafibrate Combined with Dietary Therapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13430 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Lipid metabolism and disorders |
| related_works | https://openalex.org/W2083404655, https://openalex.org/W3181917241, https://openalex.org/W2380466206, https://openalex.org/W2470777501, https://openalex.org/W4249574573, https://openalex.org/W2376448543, https://openalex.org/W2032004335, https://openalex.org/W2142163047, https://openalex.org/W2389203284, https://openalex.org/W2066679063 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.2169/internalmedicine.3946-24 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S154471048 |
| best_oa_location.source.issn | 0918-2918, 1349-7235 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0918-2918 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Internal Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310313351 |
| best_oa_location.source.host_organization_name | The Japanese Society of Internal Medicine |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310313351 |
| best_oa_location.source.host_organization_lineage_names | The Japanese Society of Internal Medicine |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Internal Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.2169/internalmedicine.3946-24 |
| primary_location.id | doi:10.2169/internalmedicine.3946-24 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S154471048 |
| primary_location.source.issn | 0918-2918, 1349-7235 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0918-2918 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Internal Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310313351 |
| primary_location.source.host_organization_name | The Japanese Society of Internal Medicine |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310313351 |
| primary_location.source.host_organization_lineage_names | The Japanese Society of Internal Medicine |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3946-24/_pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Internal Medicine |
| primary_location.landing_page_url | https://doi.org/10.2169/internalmedicine.3946-24 |
| publication_date | 2024-07-24 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3163842498, https://openalex.org/W2067802636, https://openalex.org/W4249658556, https://openalex.org/W2605150564, https://openalex.org/W2912235637, https://openalex.org/W3087164693, https://openalex.org/W2335321296, https://openalex.org/W2765263832, https://openalex.org/W2796005123, https://openalex.org/W3108098963, https://openalex.org/W2095238078, https://openalex.org/W2158027965, https://openalex.org/W4283072690, https://openalex.org/W3014184098, https://openalex.org/W2023466812, https://openalex.org/W2051973133, https://openalex.org/W2078074803, https://openalex.org/W1991208787, https://openalex.org/W2001957441, https://openalex.org/W2113481191, https://openalex.org/W2162588312, https://openalex.org/W2154292243, https://openalex.org/W2137271937, https://openalex.org/W2145856453, https://openalex.org/W2140828248, https://openalex.org/W2169934414, https://openalex.org/W2078154888, https://openalex.org/W4212988950, https://openalex.org/W2588037944, https://openalex.org/W2744310085, https://openalex.org/W2599479486, https://openalex.org/W4308367139, https://openalex.org/W4233603867 |
| referenced_works_count | 33 |
| abstract_inverted_index.2 | 37 |
| abstract_inverted_index.A | 0, 50 |
| abstract_inverted_index.a | 4, 18 |
| abstract_inverted_index.g | 29 |
| abstract_inverted_index.He | 16, 34 |
| abstract_inverted_index.In | 62 |
| abstract_inverted_index.as | 23, 25 |
| abstract_inverted_index.in | 57 |
| abstract_inverted_index.of | 8, 30, 71 |
| abstract_inverted_index.to | 13, 64, 77 |
| abstract_inverted_index.100 | 28 |
| abstract_inverted_index.and | 20, 39, 41, 60, 67 |
| abstract_inverted_index.had | 35, 42 |
| abstract_inverted_index.his | 74 |
| abstract_inverted_index.man | 2 |
| abstract_inverted_index.our | 14 |
| abstract_inverted_index.per | 32 |
| abstract_inverted_index.was | 11 |
| abstract_inverted_index.(TG) | 6 |
| abstract_inverted_index.<150 | 78 |
| abstract_inverted_index.day. | 33 |
| abstract_inverted_index.diet | 22 |
| abstract_inverted_index.from | 45 |
| abstract_inverted_index.more | 26 |
| abstract_inverted_index.than | 27 |
| abstract_inverted_index.type | 36 |
| abstract_inverted_index.well | 24 |
| abstract_inverted_index.with | 3 |
| abstract_inverted_index.APOA5 | 58 |
| abstract_inverted_index.acute | 47 |
| abstract_inverted_index.level | 7 |
| abstract_inverted_index.meals | 66 |
| abstract_inverted_index.mg/dL | 10 |
| abstract_inverted_index.11,397 | 9 |
| abstract_inverted_index.levels | 76 |
| abstract_inverted_index.mg/dL. | 79 |
| abstract_inverted_index.severe | 46 |
| abstract_inverted_index.twice. | 49 |
| abstract_inverted_index.alcohol | 31, 68 |
| abstract_inverted_index.genetic | 51 |
| abstract_inverted_index.low-fat | 65 |
| abstract_inverted_index.lowered | 73 |
| abstract_inverted_index.obesity | 40 |
| abstract_inverted_index.(c.56C>G | 59 |
| abstract_inverted_index.addition | 63 |
| abstract_inverted_index.admitted | 12 |
| abstract_inverted_index.analysis | 52 |
| abstract_inverted_index.compound | 54 |
| abstract_inverted_index.consumed | 17 |
| abstract_inverted_index.diabetes | 38 |
| abstract_inverted_index.high-fat | 19 |
| abstract_inverted_index.revealed | 53 |
| abstract_inverted_index.suffered | 44 |
| abstract_inverted_index.hospital. | 15 |
| abstract_inverted_index.mutations | 56 |
| abstract_inverted_index.c.553G>T). | 61 |
| abstract_inverted_index.cessation, | 69 |
| abstract_inverted_index.previously | 43 |
| abstract_inverted_index.50-year-old | 1 |
| abstract_inverted_index.pemafibrate | 72 |
| abstract_inverted_index.heterozygous | 55 |
| abstract_inverted_index.pancreatitis | 48 |
| abstract_inverted_index.triglyceride | 5, 75 |
| abstract_inverted_index.administration | 70 |
| abstract_inverted_index.high-carbohydrate | 21 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.23680352 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |